Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-04-30
2000-07-25
Chang, Ceila
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514183, 514212, 5142288, 5142312, 514318, 514428, 540450, 540609, 544 63, 544105, 546193, 546231, 548586, A61K 31445, C07D26500, C07D21128
Patent
active
060937335
ABSTRACT:
This invention relates to a novel class of partial or full muscarinic receptor agonists intermediates for their preparation, and pharmaceutical compositions and methods of use for the treatment or prevention of diseases the treatment or prevention of which is mediated by muscarinic receptor agonism.
REFERENCES:
patent: 5268373 (1993-12-01), Breslin et al.
Goerdeler et al. "Acyl carbodiimides II . . . " CA 87:184175, 1977.
US Congress "The biology of Mental disorders", Library of Congress, p 45-47, 55, 1992.
Liston Dane R.
Nowakowski Jolanta
Villalobos Anabella
Yohannes Daniel
Chang Ceila
Speer, Esq. Raymond M.
LandOfFree
Muscarinic receptor agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Muscarinic receptor agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Muscarinic receptor agonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1336923